Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment
Author(s) -
Hiroyuki Nakanishi,
Masayuki Kurosaki,
Kaoru Tsuchiya,
Yutaka Yasui,
Mayu Higuchi,
Tsubasa Yoshida,
Yasuyuki Komiyama,
Kenta Takaura,
Tsuguru Hayashi,
Konomi Kuwabara,
Natsuko Nakakuki,
Hitomi Takada,
Masako Ueda,
Nobuharu Tamaki,
Shōko Suzuki,
Jun Itakura,
Yuka Takahashi,
Namiki Izumi
Publication year - 2016
Publication title -
liver cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.916
H-Index - 34
eISSN - 2235-1795
pISSN - 1664-5553
DOI - 10.1159/000449337
Subject(s) - hepatocellular carcinoma , sorafenib , medicine , hazard ratio , gastroenterology , carcinoma , overall survival , confidence interval
This study aimed to build a prediction score of prognosis for patients with advanced hepatocellular carcinoma (HCC) after sorafenib treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom